Limitations of Use Do not use Priftin monotherapy in either the initial or the continuation phases of active antituberculosis
Our decision to commence antituberculosis
therapy was prompted by the last LP findings (high CSF protein, low CSF glucose, and a predominant lymphocytosis), her immunocompromised state and chronic tuberculous meningitis being the most likely explanation for her loss of vision.
As mentioned in literature, the symptoms in our patient also resolved in a short period of time with antituberculosis
An official ATS statement: Hepatotoxicity of antituberculosis
After making the diagnosis of miliary TB, four-drug combination antituberculosis
therapy with anticongestive medications was commenced.
Neolignans, especially compound (1), are potential candidates for future antituberculosis
extend duration of antituberculosis
treatment) be made to decrease relapse risk in underweight patients who do not have greater than 5% weight gain.
XDR tuberculosis is resistant to at least rifampicin, isoniazid, and one or more of the second-line antituberculosis
1 QUICKSTART 1 Surprise result (5) 6 German river (5) 9 Japanese warrior (7) 10 Out of place (5) 11 Fountain in Rome (5) 12 Glide over ice (5) 13 Cyclist's trick (7) 15 Antituberculosis
vaccine (1,1,1) 17 Cargo compartment (4) 18 Casino worker (6) 19 Changes position (5) 20 Independent school, - - - College (6) 22 Young child (4) 24 Payment (3) 25 Stops (7) 26 Of the sun (5) 27 Hardeep - - -, Sikh TV presenter (5) 28 Sierra - - -, Commonwealth country (5) 29 Appearance (7) 30 Action words (5) 31 Overexcited?
Recently there has been active interest of the antituberculosis
activities of a monohalogenated 5-CHQ against clinical Mycobacterium tuberculosis and also against Alzheimer's disease (Bondiolottie, et al.
A case of lung tuberculosis in a patient with rheumatoid arthritis treated with infliximab after antituberculosis
chemoprophylaxis with isoniazid.
Objective: Determination of antituberculosis
drug resistance rate in pulmonary tuberculosis patients producing Mycobacterium tuberculosis.
Protective effect of N-acetylcysteine on antituberculosis
New case was defined as a TB patient who has never had treatment for tuberculosis or has taken antituberculosis
drugs for less than one month (7).
The patient was started on four antituberculosis
medications, including isoniazid, rifampicin, ethambutol and pyrazinamide.